Tang Kevin C's Form 4 filing
TCR2 Therapeutics Inc. (TCRR) · filed May 10, 2023
- Accession no.
- 0001209191-23-028565
- Filed
- May 10, 2023, 7:02 PM ET
- Trade date
- May 8-10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $163.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tang Kevin CCIK 0001178579 | 10% Owner |
| Tang Capital Partners LPCIK 0001191935 | 10% Owner |
| Tang Capital Management LLCCIK 0001232621 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 8, 2023 | Common Stock | PPurchaseAcquired | +57,073 | $1.95 | +$111,292.35 | 4,272,937 | Indirect | |
| May 9, 2023 | Common Stock | PPurchaseAcquired | +20,141 | $1.95 | +$39,274.95 | 4,293,078 | Indirect | |
| May 10, 2023 | Common Stock | PPurchaseAcquired | +6,774 | $1.95 | +$13,209.3 | 4,299,852 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.